← Back|BSXBoston Scientific Corporation
44.25 USD+1.5%Healthcare
About the company

Boston Scientific develops devices that let physicians treat disease through catheters and small incisions instead of open surgery. Cardiology is the anchor: stents, heart rhythm devices, structural heart implants and tools for closing the heart's left atrial appendage. Additional franchises cover endoscopy, urology and neuromodulation. The company grows through a steady cadence of internal development and tuck-in acquisitions, and its products ride two durable currents in medicine, aging populations and the shift toward minimally invasive care.

Overall
6.5
Market Cap
$65.8B
P/E (ttm)
18.5
Analyst Target
72.43 USD
+63.7%
Data as of 04:26 ·